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ABSTRACT
BubR1 is a key protein mediating spindle check-
point activation. Loss of this checkpoint control
results in chromosomal instability and aneuploidy.
The transcriptional regulation of the cell cycle
regulated human BUB1B gene, which encodes
BubR1, was investigated in this report. A minimal
BUB1B gene promoter containing 464bp upstream
from the translation initiation codon was sufficient
for cell cycle regulated promoter activity. A pivotal
role for transcription factor hStaf/ZNF143 in the
expression of the BUB1B gene was demonstrated
through gel retardation assays, transient expression
of mutant BUB1B promoter–reporter gene con-
structs and chromatin immunoprecipitation assay.
Two phylogenetically conserved hStaf/ZNF143-
binding sites (SBS) were identified which are
indispensable for BUB1B promoter activity.
In addition, we found that the domain covering the
transcription start sites contains conserved boxes
homologous to initiator (Inr), cell cycle dependent
(CDE) and cell cycle genes homology regions (CHR)
elements. Mutations within the CDE and CHR
elements led to diminished cell cycle regulation of
BUB1B transcription. These results demonstrate
that BUB1B gene transcription is positively regu-
lated by hStaf/ZNF143, a ubiquitously expressed
factor, and that the CDE-CHR tandem element
was essential for G2/M-specific transcription of
the BUB1B gene.
INTRODUCTION
The spindle checkpoint functions to prevent premature
anaphase entry until all chromosomes have completely
aligned at the metaphase plate. BubR1 is a key protein
mediating spindle-checkpoint activation during which it is
phosphorylated. A loss of spindle-checkpoint function
inevitably results in chromosomal instability and
aneuploidy (1,2). Given that aneuploidy is prevalent in
many types of cancers, it is believed that spindle-
checkpoint failure may be at least partly responsible for
the development of cancer (3). Mouse genetics study
showed also that haplo-insuﬃciency of BubR1 resulted in
enhanced genomic instability and development of lung
and colon cancer (4,5). In synchronized cells, expression
of the BUB1B gene, which encodes BubR1, is undetect-
able in G1 but it peaks in G2/M (6,7). This cell cycle
dependent expression explains the tissue distribution and
the abundance of BubR1 mRNA in cells with a high
mitotic index (8). In this work, which represents the
ﬁrst report concerning the regulation of BUB1B gene
expression, we localized the promoter of this gene to
positions  464/ 107 relative to the translation initiation
codon. We found that the BUB1B promoter contains
three positively cis-acting motifs: one Inr-like motif and
two elements recognized by the hStaf/ZNF143 transcrip-
tion factor. This factor can up-regulate the BUB1B
promoter activity, and chromatin immunoprecipitation
assays demonstrated that the endogenous hStaf/ZNF143
is bound to the BUB1B promoter in vivo. The ZNF143
protein is the human ortholog of Staf, the Xenopus
selenocysteine tRNA
Sec gene transcription factor (9,10).
The human Staf (hStaf/ZNF143) is a seven C2-H2 zinc
ﬁnger protein capable of enhancing transcription of
the tRNA
Sec but also of the snRNA and snRNA-type
genes (10,11). hStaf/ZNF143 can also stimulate transcrip-
tion from an mRNA-type pol II promoter (10,12,13).
To date, only seven protein-coding genes have been
described to be regulated by hStaf/ZNF143: the cytosolic
chaperonin containing t-complex polypeptide 1 (TCP1)
(14); the interferon regulatory factor (IRF3) (15); the
neuronal nitric-oxide synthase (NOS1) (16); the transal-
dolase (TALDO1) (17); the aldehyde reductase
(AKR1A1) (18); the mitochondrial ribosomal protein
S11 (MRPS11) (19) and the synaptobrevin-like 1 (SYBL1)
(20). In addition, vertebrates contain the ZNF76 protein
which constitutes a ZNF143 paralog (13,21). ZNF76 and
ZNF143 are basically considered to play the same role
even though their relative expression levels diﬀer in
various tissues (13). However, recent results suggested
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through its interaction with TBP and that sumoylation
modulates its transcriptional properties (22). Very
recently, genome-wide analysis led us to identify 1175
hStaf/ZNF143-binding sites distributed in 938 mamma-
lian promoters in protein-coding genes. By extrapolating
these values to the full sizes of the genomes, we can
infer the existence of at least 2500 Staf-binding sites (SBS)
distributed in 2000 promoters. This large number
suggests that the SBS constitutes one of the most
widespread transcription factor binding sites in mamma-
lian promoters (23).
In G1/S, the transcriptional repression of many genes
such as CDC25C, CDC2, CCNA2 (coding for cyclin A),
PLK1 (polo-like kinase) and RB6K (rabkinesine 6) is
regulated by two repressor elements known as CDE
(cell cycle dependent element) and CHR (cell cycle genes
homology region). In these genes, mutation of the CDE
and CHR elements allowed elevated transcription during
G1 and the consequent loss of cell cycle regulated
expression (24–27). In the present study, we demonstrate
that the cell cycle regulation of BUB1B gene transcription
is also achieved through the presence of two elements
homologous to the repressor elements CDE and CHR.
MATERIALS AND METHODS
Reporter constructsand expression vectors
The human BUB1B promoter fragment  1185/ 31 was
PCR ampliﬁed from human genomic DNA using direct
and reverse primers incorporating SacI and BamHI sites,
respectively. The ampliﬁed product was cloned directly at
the 50-end to the luciferase reporter gene into the SacI/
BamHI digested pFLASH I vector (SynapSys). The 50-end
truncated derivatives of the  1185/ 31 fragment
( 864/ 31,  585/ 31,  464/ 31,  314/ 31,  305/
 31,  236/ 31 and  107/ 31) were PCR ampliﬁed
from construct  1185/ 31 and ligated to SacI/BamHI
cut pFLASH I. Mutant constructs were generated by
using the QuickChange II XL site-directed mutagenesis kit
(Stratagene). All constructs were veriﬁed by automated
DNA sequencing. Constructs  464/ 31 mCHR contain
the  176ATTTGAA-170 to  176CGGGTCC-170 sub-
stitution,  464/ 31 mCDE contain the  166TGGCGG-
161 to  166GTTATT-161 substitution. The Drosophila
expression vectors pPAC-ZNF76 and pPAC-ZNF143
containing the human ZNF76 and ZNF143 cDNAs
were described in (13). The oligonucleotide sequences
used in this study are available on request.
Transfectionand luciferase assays
COS-7 cells were transfected by the calcium phosphate
co-precipitation procedure with 1mg of reporter construct,
0.5mg of pCH110 plasmid as the internal control, and
carrier DNA to bring up the total DNA content to 10mg/
plate. SL2 Drosophila cells were transfected as described in
(12) with 25, 100 or 500ng of pPAC-hStaf/ZNF143 or
pPac-ZNF76, and 200ng of pACH110 as internal control.
After 48h, cells were lysed and the b-galactosidase activity
was measured as previously described (12). The luciferase
assay was performed as recommended by the manufac-
turer (Promega). The luciferase activity was normalized to
the b-galactosidase activity. Each transfection experiment
was done in triplicate.
hStaf/ZNF143 proteinpreparation and DNA-binding assay
The hStaf/ZNF143 DNA-binding domain was produced
using the glutathione S-transferase (GST) gene fusion
system. Brieﬂy, the DNA containing the Staf zinc ﬁnger
coding region between A264 and E472 was excised from
E10 (10) as a HindIII/EcoRV fragment, blunted and
inserted in the direct orientation into the SmaI site of
pGEX-2TK (GE Healthcare). The fusion protein was
puriﬁed using glutathione-sepharose beads. The glu-
tathione S-transferase moiety was cleaved with thrombin.
Full-length hStaf/ZNF143 was synthesized by in vitro
coupled transcription-translation with the TnT system
(Promega) as described in (13). Fifty microliter reactions
were programmed with 1mg of pSK(-)-ZNF143 (13).
Gel retardation assays were performed essentially as
described in (28) with 20 fmol of the labeled probe in
the presence of either the hStaf/ZNF143 DBD (1, 2, 4 and
20pmol), 2.5 and 5ml of programmed lysate or 10mgo f
HeLa cells nuclear extracts. The various probes containing
the wild-type and mutant versions of the SBS in the
BUB1B promoter were generated by PCR ampliﬁcation of
regions  342/ 196,  342/ 265,  281/ 196 using
32P-
labeled oligonucleotides.
ChIP assay
The rabbit polyclonal antipeptide antibody against a
C-terminal epitope of the Xenopus Staf (29) was used for
ChIP as essentially described in (23,30). Puriﬁed DNA was
analyzed by PCR with the test primer pair
TAAGTGTTCCTCGCTCGGCTCAGA and CTCAGA
GCACCCCCTTCCTTCTTC speciﬁc for the BUB1B
promoter and complementary to positions –427/–404
and þ12/þ35, respectively. The BUB1B control primers
CCACTGTGGGGTGCTGATGTCTGG and CGGGA
TGCGGGGGTTGC hybridized to sequences 2647–2623
and 2439–2422bp, respectively, upstream of the BUB1B
ATG initiation codon. The human tRNA
Sec gene test
primer pair hybridized to sequences  391/ 365 and
 205/ 181 of the human tRNA
Sec gene promoter.
The human tRNA
Sec control primer pair recognizes
sequences located at 2555/2530 and 2346/2321bp
upstream of the human tRNA
Sec gene. Cycling parameters
were 958C for 3min, 35 cycles at 958C for 30s, 55–658C
(depending on each primer pair) for 30s, 728C for 30s and
728C for 5min.
Cell culture, synchronization and cell cycle analysis
Transiently transfected COS-7 cells were arrested at the
G1/S boundary by a single or double thymidine block.
To block them at the M phase, cells were treated with
nocodazole. In brief, for thymidine block and nocodazole
treatment, thymidine or nocodazole were added 18h after
transfection to 2mM or 0.17mM ﬁnal concentration,
respectively. After 22h incubation, cells were harvested
and used for luciferase and ﬂow cytometry assays. For the
3454 Nucleic Acids Research, 2007, Vol. 35, No. 10double thymidine block, thymidine was added to 2mM as
the ﬁrst block. After a 16h incubation, cells were washed
twice with PBS and incubated in complete growth media
for an additional 8h. Thymidine was then added as the
second block for 16h. Subsequently, cells were washed
twice with PBS, and complete growth media was added to
release them from the block. This time point was set as 0.
Cells were harvested at various time points and used for
luciferase and ﬂow cytometry assays. For ﬂow cytometry,
cells were brieﬂy trypsinized, pelleted by centrifugation
at 200g, resuspended in PBS and ﬁxed in 75% ethanol.
After centrifugation and rehydration in PBS for 15min at
room temperature, cells were pelleted and resuspended
in 1ml of staining buﬀer containing propidium iodide
(0.5mg/ml), 0.1% Triton-X100, 0.1mM EDTA and
RNase A (25mg/ml). Cell cycle distribution was deter-
mined by analyzing their DNA content on a Becton
Dickinson FACScalibur ﬂow cytometer.
RESULTS
Characterization of theBUB1B promoter
A search at the database of transcription start sites
(DBTSS) (31,32) revealed that transcription of the BUB1B
gene is directed from multiple transcription start sites
(TSS) located in a 75-bp long region. In this report,
promoter numbering starts from the ﬁrst nucleotide of
the translation initiation codon. The TSS region is located
between positions  198 and  124, with a major
transcription start site at  178 (Figure 1A). To identify
the regions responsible for transcriptional regulation of
BUB1B, we transiently transfected COS-7 cells with
several luciferase reporter constructs containing progres-
sively deleted 50-ﬂanking regions of the BUB1B gene and
then measured the luciferase activity of the resulting cell
extracts (Figure 1A and B). The parental construct  1185/
 31 contains the region  198/ 124 covering the tran-
scription start sites. A deletion from  1185 to  586
resulted in  5-fold decrease of luciferase activity
(Figure 1B, compare constructs  864/ 31 and  585/
 31 with  1185/ 31). Further deletions from  584 to
 306 did not signiﬁcantly aﬀect the transcriptional
activity (Figure 1B, compare the activity of constructs
 464/ 31,  314/ 31 and  305/ 31 with construct
 585/ 31). An additional deletion to  237 resulted in
 10-fold decrease of activity. Strikingly, a further deletion
to  107 created a construct unable to drive transcription
of the reporter gene (Figure 1B, compare  236/ 31,
 107/ 31 and the empty vector Luc with  1185/ 31).
We concluded from the luciferase assays that transcription
of the BUB1B gene was positively regulated by two
regions, one located between  1185/ 585 and the other
between  305/ 107.
Transposable elements and potential regulatory motifs inthe
50-upstreamregion
Sequence comparison and analysis of upstream regions of
the BUB1B gene that contain orthologs in the mouse, rat
and dog genomes, revealed the presence of transposable
elements in regions homologous to  1185/ 585 in the
four genomes. Table 1 shows the occurrence of two short
interspersed nuclear elements (SINE). In addition, a
long-terminal repeat sequence (LTR) is present upstream
of the mouse and rat BUB1B genes. Computational
analysis of the  1185/ 585 region with the Matinspector
software (33) did not reveal the presence of interspecies
conserved sequences for transcription factor binding sites.
Upon computational analysis of the ﬁrst 464bp of the
BUB1B promoter, no TATA box could be found in the
vicinity of the transcription start site. The main transcrip-
tion start site at  178 is likely to function as an initiator
region (Inr) since the sequence TTAAATT located at
positions  180 to  174 is very similar to the Inr consensus
sequence YYAN(T/A)YY (34). No downstream promoter
element (DPE) was found at proximity of the main
transcription start site. Interestingly, however, two con-
sensus binding sites for the transcription factor hStaf/
ZNF143 (10,11,13) were found in the region  305/ 107
which positively regulates BUB1B gene expression. They
are called hereafter SBS for simplicity’s sake. The ﬁrst
SBS1, located at positions  305/ 288, and the second
SBS2at positions  256/ 239, were found to be inter-
species conserved at 72 and 88%, respectively (Figure 2A).
In Figure 2B, the 18-bp SBS1 and SBS2 were aligned with
the sequence of the human tRNA
Sec SBS (11) and with the
consensus sequences determined by binding site selection
(11,35). Immediately, upstream of the two SBS is found an
interspecies conserved 7bp ACTACAA motif
(Figure 2A), which does not correspond to any binding
site for known transcription factors. Furthermore,
Figure 2A shows that the  305/ 107 region contains
blocks of high sequence identity to the CHR (positions
 174/ 170) and the CDE (positions  165/ 161) (see also
Figure 6A). These elements are known to be involved in
the cell cycle regulated transcriptional repression of many
genes (24–26,36–39). In the promoter of these genes, the
CDE is generally adjacent to or 1–5bp upstream of the
CHR element (Figure 6A). This contrasts with the BUB1B
promoter where the CDE homologous motif precedes the
CHR by 4bp. Finally, the upstream 50-ﬂanking region of
the BUB1B gene contains one CpG island extending from
 415 to  50.
hStaf/ZNF143 binds to theBUB1B basal promoter
In the ﬁrst place, gel retardation assays were performed
to determine whether hStaf/ZNF143 does bind the
BUB1B promoter. To do this, the
32P-labeled DNA
fragment ( 342/ 196) encompassing the two putative
SBS (probe I in Figure 1A) was incubated with increasing
amounts of the puriﬁed hStaf/ZNF143 DNA-binding
domain (hStaf/ZNF143 DBD). Figure 3A shows that the
hStaf/ZNF143 DBD bound with high yield to the BUB1B
promoter. Increasing amounts of the protein generated
two retarded complexes (C1 and C2 in Figure 3A,
compare lane 1 with lanes 2–5). The C1 and C2 complexes
were speciﬁc because they were competed out by an
excess of unlabeled SBS of the Xenopus tRNA
Sec gene
(Figure 3A, lane 6) but not of an unrelated oligonucleotide
(Figure 3A, lane 7). We next examined the binding capac-
ities of the hStaf/ZNF143 DBD to a BUB1B promoter
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Figure 1. Identiﬁcation of the human BUB1B gene promoter and mutation analysis of promoter elements. (A) Schematic representation of the region
located 50 to the BUB1B gene. The diﬀerent elements identiﬁed are boxed. Numbering is relative to the translation initiation codon. The double-
headed arrow depicts the region containing the various TSS. Gel shift probes I, II and III are diagrammed below the promoter. (B) Schematic
representation of the 50-deleted BUB1B promoter-luciferase constructs and their activities in COS-7 cells. Cells were transiently transfected with the
50-deleted BUB1B promoter-luciferase (Luc) constructs and assayed for luciferase activity. Values are given as relative luciferase activity normalized
to 100 for the longest promoter construct  1185/ 31. Data are presented as the mean þ/ SD of three separate experiments. (C) Schematic
representation of BUB1B promoter-luciferase constructs mutated in the Inr-like motif, SBS1 and SBS2 elements and their activities in COS-7
transfected cells. Wild-type and mutant elements are boxed in black and gray, respectively. The relative luciferase activity in % was normalized to
100 with the  464/ 31 construct. Data are presented as in (B).
3456 Nucleic Acids Research, 2007, Vol. 35, No. 10carrying alterations in the SBS. Three mutant versions
of the BUB1B promoter were engineered. In mSBS1,
the CCCA sequence at positions 3–6 of SBS1 was replaced
by AAAC; the same mutation was introduced in the
SBS2 sequence to yield mSBS2. The mSBS1-2 construct
combined both mutations simultaneously. It appeared
that formation of the retarded complexes was strictly
dependent on the SBS integrity. Indeed, whereas mSBS1
and mSBS2 enabled formation of one single retarded
complex only (Figure 3B, compare lanes 5–7), the
simultaneous presence of both mutations in mSBS1-2
completely abrogated DBD binding (Figure 3B, lane 8).
The binding to wild-type or mutant BUB1B promoter
of the full-length hStaf/ZNF143, produced from pro-
grammed rabbit reticulocyte lysate, was further evaluated.
As observed with the DBD, increasing amounts of
protein generated the characteristic C1 and C2 complexes
(Figure 3C, lanes 2 and 3) which are speciﬁc since they
disappear in the presence of an excess of the wt SBS
but not with an unspeciﬁc competitor (Figure 3C, lanes 4
and 5). This binding pattern is strictly dependent on
the SBS integrity because the combined presence of
the mSBS1 and mSBS2 mutation totally abrogated
hStaf/ZNF143 binding (Figure 3C, lane 7).
To ask whether hStaf/ZNF143 is expressed in HeLa
cell, we performed gel retardation assays with HeLa cell
nuclear extracts and probes II and III containing SBS1
and SBS2, respectively. In such an experiment, we expect
ﬁnding one single complex with each of the probe.
This was eﬀectively the case, as shown in Figure 3D
(lanes 2 and 10). The speciﬁcity of binding was attested
by the competition obtained with an unlabeled hStaf/
ZNF143 consensus oligonucleotide (Figure 3D, lanes 3, 4,
11) but not with an unrelated unlabeled oligonucleotide
(Figure 3D, lanes 5, 6, 12). The presence of hStaf/ZNF143
in the complex was assessed by the displacement of the
complexes observed with an anti-hStaf/ZNF143
(Figure 3D, lanes 7 and 13) but not with a pre-immune
antibody (Figure 3D, lanes 8 and 14). To further validate
these ﬁndings, the association of hStaf/ZNF143 to the
human BUB1B promoter in vivo was investigated with the
chromatin immunoprecipitation assay (ChIP). Chromatin,
formaldehyde cross-linked with sheared DNA 0.5–1kbp
in length, was prepared from HeLa cells and incubated
with an antipeptide antibody directed against the
C-terminal part of hStaf/ZNF143 (29) or with a control
pre-immune antibody. The recovered DNA was analyzed
by semi-quantitative PCR with primers spanning the SBS
of the BUB1B promoter (test sequence) or a region
located 2.5kbp upstream of it (control sequence). The
analysis was performed with two dilutions of the DNA
obtained from anti-hStaf/ZNF143 and pre-immune ChIP.
We also tested a serial dilution of the input material to
demonstrate that the PCR was quantitative within a linear
range of concentration. A speciﬁc signal, absent with the
pre-immune antibody, was obtained with the DNA
immunoprecipitated with the hStaf/ZNF143 antibody
(Figure 4A, compare lanes 1, 2 and 3, 4 of the test).
In contrast, no speciﬁc signal could be obtained with the
control primer pair (Figure 4B, lanes 1–4 in the control).
As an additional control, the same DNA samples were
used to show the binding of hStaf/ZNF143 to the human
tRNA
Sec gene promoter, known to be targeted by hStaf/
ZNF143 (11) (Figure 4B). As expected, a speciﬁc signal
was obtained only for the PCR reaction using the DNA
immunoprecipitated with hStaf/ZNF143 and performed
with the test primer pair (compare lanes 2 and 3 of the test
and control reactions). Collectively, these results demon-
strate the presence of two SBS and the association of
hStaf/ZNF143 to the BUB1B promoter in vivo.
Effects of hStaf/ZNF143-binding site and Inrmutations on
BUB1B promoter activity
The eﬀect of the debilitating mutations mSBS1, mSBS2
and mSBS1-2 was assessed in vivo by introducing them
into construct  464/ 31 (Figure 1C). The mutant
constructs were then transfected into COS-7 cells and
promoter activities were reported by the luciferase activity.
Mutation of the SBS1 and SBS2 resulted in a slight
decrease to 78 and 61% of the wild-type level, respectively
(Figure 1C). The simultaneous mutation, however,
induced a much more pronounced eﬀect since the activity
dropped to 19% of the wt level (Figure 1C), indicating
that SBS1 and SBS2 are of prime importance to BUB1B
promoter activity. We also observed that the TTAAATT
sequence (positions  180 to  174) is very similar to the
Inr consensus sequence YYAN(T/A)YY (34). To test the
functional importance of this interspecies conserved motif,
the TTAAATT sequence was changed to TTCCCTT.
The activity of the luciferase reporter decreased to 49% of
the wild-type level (mInr in Figure 1C). From this data, we
Table 1. Characteristics of the transposable elements localized in the 50 region of the human, dog, mouse and rat BUB1B genes
Organism Element Name Size (bp) Family Class Position/ATG
Human 1 FRAM 180 Alu SINE  1062/ 882
Human 2 MIRb 115 MIR SINE  698/ 583
Dog 1 SINEC CF3 166 Lys SINE  1256/ 1090
Dog 2 MIRb 108 MIR SINE  744/ 636
Mouse 1 LTR 568  1609/ 1041
Mouse 2 B1_Mus2 69 Alu SINE  1040/ 971
Mouse 3 PB1 82 Alu SINE  929/ 849
Rat 1 LTR 541  1570/ 1029
Rat 2 B1_Rn 73 Alu SINE  1028/ 956
Rat 3 PB1D10 92 Alu SINE  921/ 830
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motif lies in the BUB1B promoter.
Transcriptional activation ofthe BUB1B promoter in
Drosophila Schneider cells
To further conﬁrm the role of hStaf/ZNF143 in BUB1B
gene transcription and to investigate whether ZNF76, the
human paralog of hStaf/ZNF143, can functionally inter-
act with the BUB1B promoter, transient transfection
experiments were performed with Drosophila SL2 cells.
This model oﬀers the advantage to lack many of the
homologs to vertebrate transcription factors, in particular
ZNF143 and ZNF76 (12,13). Thus, eﬀectors for ZNF143
(pPac-hStaf/ZNF143), ZNF76 (pPac-ZNF76) (13) and the
empty vector pPac under the control of SL2-speciﬁc
promoter, were co-transfected along with the luciferase
reporter gene under the control of the wild-type  436/ 31
BUB1B promoter. The eﬀect on promoter activity of
varying the intracellular level of ZNF143 or ZNF76 was
assessed by introduction of increasing amounts of the
expression vectors (Figure 5A). Expression from the pPac-
hStaf/ZNF143 or pPac-ZNF76 expression vectors was
conﬁrmed by gel retardation assays with SL2 extracts and
probe II containing SBS1 (Figure 1A). No binding was
observed with extracts from untransfected or empty-pPac
transfected SL2 cells (Figure 5B, compare lane 1 with
lanes 2 and 3). In contrast, increasing the amount of
expression vectors in the transfection led to higher yield of
retarded complexes (Figure 5B, compare lane 1 with lanes
4–6 and 7–9). As ZNF143 and ZNF76 recognize a same
DNA motif with identical aﬃnities (13), the yield of the
complexes is a gauge of the expression of hStaf/ZNF143
and ZNF76 in SL2 cells (Figure 5B, lanes 4–9). In these
assays, the luciferase activity in cells extracts was normal-
ized to the amount of the eﬀector proteins. ZNF143 and
ZNF76 exhibited a dose dependent transactivation eﬀect
on the  464/ 31 promoter, reaching 24-fold for ZNF143
and 8-fold for ZNF76 compared to the empty vector pPac
(Figure 5A). We concluded that ZNF76 and ZNF143 can
mediate the transcriptional activation of the BUB1B
promoter in Drosophila SL2 cells.
Transcription ofBUB1B is regulated during thecell cycle
We next analyzed the cell cycle dependent transcription of
BUB1B by assessing the luciferase activities of the  464/
 31 construct transfected into COS-7 cells that had been
synchronized in G1/S by a double thymidine block. After
the cells were released from the block, the luciferase
activities at the indicated time points were measured and
normalized (Figure 6A). Most the cells were in G1/S at the
start of the experiment. As the cells entered in the S phase,
the  464/ 31 associated luciferase activity increased with
an optimum  9–13h after the release when most of the
cells were in G2/M. In contrast, similar experiments using
a3 0-truncated promoter containing only the two SBS
(construct  464/ 196) resulted in a signiﬁcant increase in
reporter activity in G1/S which remained high throughout
the cell cycle (Figure 6A). To test whether the binding of
hStaf/ZNF143 to the SBS of the BUB1B promoter is cell
cycle dependent, we performed gel retardation assays
A
B
  -464
h TCCCAACACTCAAAACAGCAAAGAAGTTCTGGTGCTTTAAGTGTTCCTCGCTCGGCTCAG
d TCTCTATGTTCAAAACAGCAAAGAAATTCTAGTGCTTGCGGTGTCCCTCCCTCGGTTCAG
m TTATGAAACTGAAACCATCAAAGAACCTCTTGTTAATAAAGTGTCTCTCCCTGGGTTCGA
r TG-------------TACTCAAAGACATCTTGTTATTAAGGTGTCCCTCCCTGGGTTCGA
  *               *   **  *  *** **   *   ****  *** ** ** **  
  -404
h AGACTCGGCTTCGAGCCGCGACTCAAGACAGCACCTG-GGGGTATTTGTTTTGCCTAAGC
d AGACT--------GGCCCTAATTTAGAAGAGCTCTTGCAGAGAATTGACCCCGCCTCAAC
m AGGCTTGTCTTAGAAAGGAAACACAGAGCAAACTCGAAG--TGCCTGAGCACGCTGCAGT
r AGACTTGCCTTAAAGAGGAAACACAGAGTAAAGCTGAAGCTTGCCTGAGCCTGCTGCAGT
  ** **               *   *    *               *      **   *  
  -345
h CTGCTGCACTTCCACGGCCATTGAATCCCAA-----AAACTACAA
d CGGGGCGTACTGGGCAGCCACAAACTCCCGG----GAAACTACAA
m GCTAGGACAACCATTGGTCCTTGCACCTCAAACCTGAAACTACAA
r GCCAGGACAACCACTGGCCGCTTC---------CCGAAACTACAA
                  * *                 ********* ******* ****  
  -290
h GCGAGTTCGCGGACTAAACA—-GGCATAAACTACAAGCCCCAGAATGCCTTGGGCGAGA-
d ACGACAGTGGGGACTAAACCCCGAGATAAACTACAAGCCCCAGAATGCCTTGGGGGGGGG
m GCG-CAGCGCGTGCTTAAACCCGGGATACACTACAATCCCCAGAATGCTTTGGGAGGAG-
r GCG-CAGCGCGGGCTTAAACCCGGGATGCACTACAATCCCCAGAATGCTTTGGGAGGAG-
   **     * *  ** **    *  **  ******* *********** ***** *    
  
h -------------CGCGAGAGC-------------------------ACGGAGGAGCGGA
d GGTGGAGAGAGCGCGCGAGAGCGAGAGAGAGCGAGAGAGACGCGAGTACAAAGGGGCGGA
m ------------------------------------------------CGGGAGCGGGGA
r ------------------------------------------------CGAGGCGGGGAT
                                                  *      * *  
 -211
h GGGGCGTGGCCACGTCGACCGCGCGGGACCGTTAAAT AACTTGGCGGC--------
d GGGGCGTGTTCACGTCCGACGCGCGGGACCGTTAAAT AACTTGGAGGG--------
m GCGGCGAGGCTACGTCTG-CGTCAAGAGACGTTAAAT AACTTGGCGGCCCGTGCGT
r GCGGCCACGCTACGTCTG-CGTCCGGAGACGTTAAAT AAGTTGGCGGCCCTGGCGT
  * ** *     *****   **    *   ************** **** **         
  -159
h --TAGGG--GTGTGGGCTTGAGGTGGCCGGTTTGTTAGGGAGTCGTGTACGTGCCT----
d --TTGGA--G-GTGG---CTGGTTTGCCAAGGAGTCAGGGGCAAACCTTTGTCTCTC---
m GATGGGGGCGTGAGGAGGCTATTCTGAGAAGGAATCGGGTGCGTGGTTTTGTTTAGGAGC
r GATGGGG-CGTGAGGTAGTTTCTTTGAGACGGATTCGGGCGAGTGATTTTGTTTAGGAGT
    * **   * * **          *        *  **        *  **        
  -107
h ------TGGTCGCTTCTGTAGCTCCGAGGGCAGGTT---GCGGAAGAAAGCCCAGGCGGT
d ------TGGTCGCTTCGTTATCTTTAAGGGCAGGTA---GCAGAAGAAAGCTCAGGCGGT
m ACGGGGTGACGATCTTCGCAGCTCCAGAGCCAGCTGAAGGTTGAGGGAGACTCAG----T
r ACGGGATAACGGTCTTCGCAGCTCCAGAGTTAGCTGAAGGTTGAGGGAAGCTCAGACAGT
        *       *    * **     *  ** *    *  ** * *  * ***    *
  -56
h CTGTGGCCC-AGAGGAAAGGCCTGCAGCAGGACGAGGACCTGAGCCAGGAATGCAGGATG
d CTGCGGCCC-TGAAGAAAGGTCTGCGGCAGGACGAGGGCTCCAACCGGGAATGCAGG
m TAGCACTCGGAGGATAAAGGTCTGCGGAAGGGCGAGAGCAAGTATTGGGAATGCAGG
r TGGCACTCCGAGGAAAAAGGTCTGCGGACGGGCGAGAGCAAGAACTTGGAATGCAGG
    *    *   *   ***** **** *  ** ****  *        *************
  +4
h GCGGCGGTGAAGAAGGAAGGGGGTGCTCTGAG
d GCGGCGATGAAGAAGGAAGGGGATGCTCTGAG
m GCGGAGGCGAG---------------------
r GCGGCGGCGAG---------------------
  ****    *                       
ATTCCCATTATGCACC
ACTCCCATTATGCATC
ACTCCCATTGTGCATT
ACTCCCATTATGCACC
GCGA
ACGA
GCG
GCG
GCCCCAGAATGCCTTGGG
GCCCCAGAATGCCTTGGG
TCCCCAGAATGCTTTGGG
TCCCCAGAATGCTTTGGG
TTTGAA
TTTGAA
TTTGAA
TTTGAA
GGCGG
GGAGG
GGCGG
GGCGG
SBS1
SBS2
CHR CDE
+1
GATG
GATG
GATG
GATG
-233
SBS1          
SBS2       
htRNASec     
SBS cons.1  
SBS cons.2      
Inr
TACCCATAATGCATYGCG
YWCCCRNMATSCMYYRCR
TTCCCATTATGCACCGCG
GCCCCAGAATGCCTTGGG
TTCCCAGAATGCGTGGCG
 ****  **** * * *
Figure 2. Cross-species conservation of putative promoter elements in
the promoter regions of BUB1B homologous genes. (A) Nucleotide
sequence comparison of the human (h), dog (d), mouse (m) and rat (r)
BUB1B promoters. Multiple sequence alignments performed with
Clustal W covering the  464/þ35 part of the human promoter.
Identical nucleotides are indicated with a star. Numbering is relative to
the translation initiation codon. The SBS1, SBS2, elements homologous
to CHR and CDE motifs, and translational start codon are highlighted
in gray. The Inr-like motif and ACTACAA submotif are in bold.
(B) Comparison of the SBS1 and SBS2 sequences of the BUB1B
promoter, SBS of the human tRNA
Sec (htRNA
Sec) gene (11) and SBS
consensus sequences determined by binding site selection at highly
(Staf cons.1) (35) or moderately stringent selection conditions (Staf
cons.2) (11), (Y, W, R, N, M and S stand for T/C, A/T, A/G, any
nucleotide, A/C and G/C, respectively). Identical nucleotides are
indicated with a star.
3458 Nucleic Acids Research, 2007, Vol. 35, No. 10using probe II (Figure 1A) containing the SBS1 and
nuclear extracts from synchronized COS-7 cells. Figure 6B
shows that the binding of hStaf/ZNF143 was similar
with cells in the G1/S and G2/M cell cycle. In the light of
these ﬁndings, we speculated that hStaf/ZNF143 did
not play a central role in the G2/M-speciﬁc transcription
of BUB1B and that another mechanism must be
involved in the G2/M speciﬁcity. Indeed, transcription of
the TCP1 (14), IRF3 (15), TALDO1 (17), MRPS11 (19)
and SYBL1 genes (20) is controlled by hStaf/ZNF143
but is not cell cycle dependent (7). Furthermore,
expression of the ZNF143 gene is known not to be cell
cycle regulated (7).
Effects of mutationsin theCDE and CHR homologous
elements on thecell cycle dependent BUB1B transcription
activity
The G2/M speciﬁc transcription of many genes such as
CDC25C, CDC2, CCNA2, PLK1 and RB6K
(24,26,27,40) is regulated by a tandem of repressor
elements, the cell cycle dependent element (CDE) and
the cell-cycle genes homology region (CHR). We found
that two sets of sequences at positions  174/ 170 and
 165/ 161 bear a strikingly high similarity to the
CHR and CDE consensus sequences (Figure 2A).
The diﬀerence resides in their relative organization,
1
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Figure 3. hStaf/ZNF143-binding assays on wild-type and mutant versions of the BUB1B promoter. (A) Gel retardation assay with a fragment
encompassing positions  342/ 195 of the BUB1B promoter. The
32P labeled DNA (probe I) was incubated in the absence (lane 1) or presence of
increasing amounts of hStaf/ZNF143 DBD (lanes 2–5). The reactions in lanes 6 and 7 were performed with the same amount of protein as in lane 5
but in the presence of a 1000-fold excess of unlabeled speciﬁc (wt SBS) and unspeciﬁc competitors (unsp). Binding assays in lanes 1–5 and 6, 7 were
performed in separate experiments. C1 and C2: complexes containing one and two proteins, respectively. (B) A 148-bp 50 end-labeled fragment
containing the wild-type or mutant versions of the SBS was used in the binding studies. Lanes 1–4, no protein added. Lanes 5–8 binding assays with
the same amount of DBD. Probes are indicated above the lanes. (C) The wt (lanes 1–5) or the SBS1 and SBS2 mutant version borne by probe I
(lanes 6 and 7) were incubated in the absence (lanes 1 and 6) or presence of increasing amounts of rabbit reticulocyte lysate containing full-length
hStaf/ZNF143 (lanes 2 and 3). Lane 7 contained the same amount of protein as in lane 3. Lanes 4 and 5 were performed with the same amount of
protein as in lane 3 but in the presence of a 1000-fold excess of unlabeled speciﬁc (lane 4, wt SBS) and unspeciﬁc competitor (lane 5, unsp),
respectively. C1 corresponds to both sites of the probe saturated with the protein; the protein binds to one of the sites only in C2. (D) Gel retardation
assay with the wt probes II (lanes 1–8) or III (lanes 9–14) in the absence (lanes 1 and 9) or presence (lanes 2–8 and 10–14) of HeLa cell nuclear
extracts (NE). The reactions in lanes 3, 4 and 11, 5, 6 and 12, 7 and 13, 8 and 14 were performed in the presence of unlabeled speciﬁc competitor
(wt SBS), unspeciﬁc competitor (unsp), anti-hStaf/ZNF143 and pre-immune antibody, respectively. The speciﬁc competitor was added at a
500-fold (lane 3) and 1000-fold molar excess (lanes 4, 11). A 500 and 1000-fold molar excess of unspeciﬁc competitor was contained in lanes 5 and 6,
12 respectively. The arrow points to the complexes mentioned in the text.
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promoter (Figure 7A). These observations suggest that the
two putative cis-elements can also function as a G1/S-
speciﬁc repressor, as previously reported for the G2/M-
speciﬁc genes. To test the hypothesis, we introduced
mutations in the putative CHR and CDE motifs (mCHR
and mCDE in Figure 7B). After transfection into COS-7
cells, the luciferase activity was measured in cells arrested
in G1/S with thymidine or in G2/M phase transition by
nocodazole (Figure 7C). Drug treatment resulted in the
synchronization of at least 85% of the cells in the various
phases as determined by propidium iodine staining and
ﬂow cytometry (data not shown). The luciferase activity in
extracts of cells transfected with the wild-type  464/ 31
and arrested in G1/S was 2.2-fold lower than that from
cells arrested in G2/M (Figure 7C and D). In contrast,
transfection of the CHR and CDE mutants of the BUB1B
promoter-luciferase constructs abolished cell cycle peri-
odicity and resulted in a 2.8- and 3.1-fold enhanced
transcription activity relative to the wild-type level in G1/S
arrested cells (Figure 7C and D). In G2/M arrested cells
transfected with the CHR and CDE mutants, however,
the measured activities were similar to the wild-type
(Figure 7C and D). These results strongly suggest that
CDE and CHR act as G1/S-speciﬁc repressor elements in
the BUB1B promoter and are essential for the cell cycle
expression of this gene.
DISCUSSION
The BUB1B gene, which is highly expressed in cells with a
high mitotic index, exhibits a cell cycle dependent
expression with an undetectable transcription in G1 and
a gene expression peak in G2/M (6,7). In the present
study, we investigated the transcriptional regulation
mechanism of the human BUB1B gene. We identiﬁed
that regions  1185/ 585 and  305/ 107 in the promoter
are involved in the transcriptional regulation of the
BUB1 gene. Region  1185 to  585, which performs a
positive regulation on BUB1B gene expression, contains
two transposable elements. Sequence comparison of the
regions homologous to  1185/ 585 in other mammalian
Test
Control
Ab-ZNF143
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12 3
 h  tRNASec promoter
Pi Ab-ZNF143 Input
123 46 5 8 79
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Control
 BUB1B  promoter 
B
A
Figure 4. hStaf/ZNF143 is associated to the BUB1B gene promoter in
HeLa cells. Genomic DNA fragments, recovered from input material or
immunoprecipitated with hStaf/ZNF143 or pre-immune antibodies,
were subjected to PCR ampliﬁcation with primer pairs speciﬁc for the
promoter or upstream regions. (A) PCR analysis of the BUB1B
promoter. Lanes 1, 2 and 3, 4: two diﬀerent amounts (1 and 5%) of
immunoprecipitated DNA with hStaf/ZNF143 (Ab-ZNF143) or pre-
immune antibodies (Pi), respectively. Lanes 5–9: increasing amounts of
input material (0.002, 0.01, 0.05, 0.2 and 1%) were analyzed to
demonstrate that the assays were within the linear range of PCR
ampliﬁcation. PCR primer pairs were speciﬁc for the promoter region
of the BUB1B gene (test assay) or for a unique region located  2.5kbp
upstream of the BUB1B gene (control assay). (B) PCR ampliﬁcation
was performed with a primer pair speciﬁc for the human tRNA
Sec
(htRNA
Sec) gene promoter (test assay) or a region located 2.4kbp
upstream of it (control assay). Lanes 1, PCR performed with 0.01%
of input DNA. Lanes 2 and 3, PCR performed with 1% of DNA
recovered from ChIP.
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Figure 5. hStaf/ZNF143 and ZNF76 transactivate the human BUB1B
promoter in Drosophila Schneider cells. (A) SL2 cells were cotransfected
with the  464/ 31 luciferase reporter gene construct and increasing
amounts of empty pPac, pPac-hStaf/ZNF143 or pPac-ZNF76 expres-
sion vectors (25ng, solid boxes; 100ng, gray boxes; 500ng, open
boxes). Data are expressed as the fold of induction of luciferase activity
normalized to that obtained following co-transfection of the reporter
with the empty vector pPac. Values are the mean þ/ SD of at least
three independent transfection experiments. (B) Expression of ZNF76
and hStaf/ZNF143 in transfected SL2 cells. Expression of the proteins
in SL2 cells was conﬁrmed by gel retardation assays. The wt probe II
containing SBS1 was incubated with untransfected SL2 extracts
(lane 2), transfected SL2 extracts with empty pPac (lane 3), transfected
SL2 extracts with pPac-ZNF76 (lanes 4–6) or pPac-hStaf/ZNF143
(lanes 7–9). Lanes 4 and 7, 5 and 8, 6 and 9: probes incubated
with extracts from SL2 cells transfected with 25, 100 and 500ng of
eﬀectors, respectively.
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Figure 7. Eﬀects of mutations of the CDE and CHR elements on the BUB1B promoter activity. (A) Alignment of the CDC25C, CDC2, CCNA2,
PLK1 and RB6K promoter sequences in the region of the CDE and CHR elements (25–27). CDE and CHR elements are highlighted in gray. The
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transcription factor binding sites. This suggests that the
positive regulation is performed by species-speciﬁc ele-
ments. Similar to other cell cycle regulated genes, the
BUB1B promoter does not possess a TATA box and,
as a consequence, gives rise to many transcription
start sites. We identiﬁed ﬁve interspecies conserved
cis-acting elements in the 50-ﬂanking region  305
to  107, and a trans-acting factor involved in the control
of BUB1B gene expression. Three cis-acting motifs
positively regulate transcription and the other two
constitute a cell cycle dependent transcriptional repressor.
The motif surrounding the major transcription start site is
likely to function as an initiator. The other two positively
cis-acting motifs, SBS1 and SBS2, are speciﬁcally recog-
nized by hStaf/ZNF143 which itself was found associated
to the BUB1B promoter in HeLa cells. Mutations of SBS1
and SBS2, singly or in combination, led to a sharp
decrease of reporter activity. Analysis of the BUB1B
promoter activity in insect cells demonstrated that hStaf/
ZNF143 and ZNF76 can reconstitute BUB1B promoter
activity. Although Staf was originally identiﬁed as the
transcription factor regulating tRNA
Sec gene transcrip-
tion, it also controls snRNA, snRNA-type and mRNA
gene expression (10,11,14–20,41). The present study
extends the role of hStaf/ZNF143 to BUB1B gene
transcription. The two identiﬁed SBS1 and SBS2 sites,
distant by 31bp, were found associated to the 7bp
ACTACAA motif which lies immediately 50 to the SBS.
This motif, under our conditions, is apparently not
involved in transcription activity of the BUB1B promoter
since we observed that the 50 deletion eliminating the
ACTACAA sequence did not aﬀect promoter activity.
Scrutiny of the sequences ﬂanking the SBS in snRNA and
snRNA-type genes did not reveal the presence of an
ACTACAA-associated motif. In contrast, it is found in
the SBS characterized in the SYBL1 promoter (20) and in
58% of the SBS that we recently identiﬁed by a genome
scale analysis (23). The ﬁnding that the SBS are essential
for expression of the BUB1B gene raises the interesting
question of whether hStaf/ZNF143, the main activating
factor of the Staf family, is involved alone in transcription
activation of the BUB1B gene. Alternatively, could
ZNF76 also play a role in the expression of this gene?
Although the ChIP assay was performed with antibodies
recognizing speciﬁcally hStaf/ZNF143, this does not
exclude the possibility that ZNF76 can also be involved
in BUB1B expression.
The other two cis-acting motifs that we identiﬁed are
localized in the region covering the transcription start site
and we showed that they function as cell cycle dependent
repressor elements. They harbor high identity with the
consensus sequences of the CDE (G/CGCGG) and CHR
(TTGAA) elements identiﬁed in the cell cycle regulated
promoter genes such as CDC25, CDC2, CCNA2 (coding
for cyclin A), PLK1 (polo-like kinase) and RB6K
(rabkinesine 6) (24–27). These two elements are known
to induce repression of transcription and we established
that their mutation led to almost complete impairment of
the cell cycle dependent transcription activity of the
BUB1B promoter. Worth of note, however, the tandem
repressor element is organized in the CHR-CDE conﬁg-
uration in the BUB1B gene whereas the arrangement
CDE-CHR occurs in all the other identiﬁed repressors.
Careful inspection of the promoter sequences of other
genes known to be regulated with a tandem of CDE and
CHR repressor elements pointed to the presence of SBS in
the promoters of the RBL2 (p130 protein), PLK1 (polo-
like kinase protein) and BIRC5 (survivin protein) genes
(26,38,42,43) (Table 2). Studies on genes that are cell cycle
regulated by the CDE-CHR tandem of repressor elements
(CDC25C, CDC2 and aurora A) revealed that ubiqui-
tously expressed transcription factors such as Sp1, NF-Y
and E4TF1 act positively by binding to target sequences
upstream of the CDE-CHR motifs (36,39,40). The cell
cycle dependent repression of upstream activators via the
CDE and CHR elements has been established as the major
regulatory mechanism (36,40). As shown by genomic
footprinting on these promoters, both CDE and CHR
elements are protected in a periodic fashion, suggesting
involvement of a speciﬁc factor. A binding activity termed
CDF-1 has been identiﬁed and proposed to interact with
both CDE and CHR in the CDC25C gene promoter (44).
In a further work, a factor (CHF) interacting speciﬁcally
with CHR has been isolated in the CCNA2 gene
promoter, encoding cyclin A (45). In the situation
described for the CDC25C promoter, it was proposed
that CDF-1 presumably functions by speciﬁcally repres-
sing the NF-Y mediated activation (44). However, no
further characterization of the CDF-1 and CHF com-
plexes was undertaken. Recently, a very interesting
mechanism was reported to involve the CDE and CHR
elements in chromatin remodeling of the CCNA2 promo-
ter. In this case, the CDE-CHR tandem which is needed
for repression in quiescent cells, was also demonstrated to
be required for organizing the chromatin structure speciﬁc
for the inactive promoter (46). However, this particular
nucleosome organization becomes disorganized as a
consequence of mutations in the CDE-CHR repressor
element. In the case of the BUB1B promoter, we have
clearly demonstrated the functionality of the CDE-CHR
tandem as a repressor element, but the precise underlying
mechanism remains to be investigated.
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3462 Nucleic Acids Research, 2007, Vol. 35, No. 10Funding to pay the Open Access publication charges for
this article was provided by the Centre National de la
Recherche Scientiﬁque.
Conﬂict of interest statement. None declared.
REFERENCES
1. Lengauer,C. (2003) Cancer. An unstable liaison. Science, 300,
442–443.
2. Bharadwaj,R. and Yu,H. (2004) The spindle checkpoint, aneu-
ploidy, and cancer. Oncogene, 23, 2016–2027.
3. Lengauer,C., Kinzler,K.W. and Vogelstein,B. (1998) Genetic
instabilities in human cancers. Nature, 396, 643–649.
4. Dai,W., Wang,Q., Liu,T., Swamy,M., Fang,Y., Xie,S.,
Mahmood,R., Yang,Y.M., Xu,M. et al. (2004) Slippage of
mitotic arrest and enhanced tumor development in mice with
BubR1 haploinsuﬃciency. Cancer Res., 64, 440–445.
5. Rao,C.V., Yang,Y.M., Swamy,M.V., Liu,T., Fang,Y.,
Mahmood,R., Jhanwar-Uniyal,M. and Dai,W. (2005) Colonic
tumorigenesis in BubR1þ/ ApcMin/þ compound mutant mice is
linked to premature separation of sister chromatids and enhanced
genomic instability. Proc. Natl Acad. Sci. USA, 102, 4365–4370.
6. Davenport,J.W., Fernandes,E.R., Harris,L.D., Neale,G.A. and
Goorha,R. (1999) The mouse mitotic checkpoint gene bub1b, a
novel bub1 family member, is expressed in a cell cycle-dependent
manner. Genomics, 55, 113–117.
7. Whitﬁeld,M.L., Sherlock,G., Saldanha,A.J., Murray,J.I., Ball,C.A.,
Alexander,K.E., Matese,J.C., Perou,C.M., Hurt,M.M. et al. (2002)
Identiﬁcation of genes periodically expressed in the human cell cycle
and their expression in tumors. Mol. Biol. Cell, 13, 1977–2000.
8. Li,W., Lan,Z., Wu,H., Wu,S., Meadows,J., Chen,J., Zhu,V. and
Dai,W. (1999) BUBR1 phosphorylation is regulated during mitotic
checkpoint activation. Cell Growth Diﬀer., 10, 769–775.
9. Tommerup,N. and Vissing,H. (1995) Isolation and ﬁne mapping of
16 novel human zinc ﬁnger-encoding cDNAs identify putative
candidate genes for developmental and malignant disorders.
Genomics, 27, 259–264.
10. Schuster,C., Myslinski,E., Krol,A. and Carbon,P. (1995) Staf, a
novel zinc ﬁnger protein that activates the RNA polymerase III
promoter of the selenocysteine tRNA gene. EMBO J., 14,
3777–3787.
11. Schaub,M., Myslinski,E., Schuster,C., Krol,A. and Carbon,P.
(1997) Staf, a promiscuous activator for enhanced transcription by
RNA polymerases II and III. EMBO J., 16, 173–181.
12. Schuster,C., Krol,A. and Carbon,P. (1998) Two distinct domains in
Staf to selectively activate small nuclear RNA-type and mRNA
promoters. Mol. Cell. Biol., 18, 2650–2658.
13. Myslinski,E., Krol,A. and Carbon,P. (1998) ZNF76 and ZNF143
are two human homologs of the transcriptional activator Staf.
J. Biol. Chem., 273, 21998–22006.
14. Kubota,H., Yokota,S., Yanagi,H. and Yura,T. (2000)
Transcriptional regulation of the mouse cytosolic chaperonin
subunit gene Ccta/t-complex polypeptide 1 by selenocysteine tRNA
gene transcription activating factor family zinc ﬁnger proteins.
J. Biol. Chem., 275, 28641–28648.
15. Mach,C.M., Hargrove,B.W. and Kunkel,G.R. (2002) The small
RNA gene activator protein, SphI postoctamer homology-binding
factor/selenocysteine tRNA gene transcription activating factor,
stimulates transcription of the human interferon regulatory factor-3
gene. J. Biol. Chem., 277, 4853–4858.
16. Saur,D., Seidler,B., Paehge,H., Schusdziarra,V. and Allescher,H.D.
(2002) Complex regulation of human neuronal nitric-oxide synthase
exon 1c gene transcription. Essential role of Sp and ZNF family
members of transcription factors. J. Biol. Chem., 277, 25798–25814.
17. Grossman,C.E., Qian,Y., Banki,K. and Perl,A. (2004) ZNF143
mediates basal and tissue-speciﬁc expression of human transaldo-
lase. J. Biol. Chem., 279, 12190–12205.
18. Barski,O.A., Papusha,V.Z., Kunkel,G.R. and Gabbay,K.H. (2004)
Regulation of aldehyde reductase expression by STAF and CHOP.
Genomics, 83, 119–129.
19. Ishiguchi,H., Izumi,H., Torigoe,T., Yoshida,Y., Kubota,H., Tsuji,S.
and Kohno,K. (2004) ZNF143 activates gene expression in response
to DNA damage and binds to cisplatin-modiﬁed DNA.
Int. J. Cancer, 111, 900–909.
20. Di Leva,F., Ferrante,M.I., Demarchi,F., Caravelli,A.,
Matarazzo,M.R., Giacca,M., D’Urso,M., D’Esposito,M. and
Franze,A. (2004) Human synaptobrevin-like 1 gene basal tran-
scription is regulated through the interaction of selenocysteine
tRNA gene transcription activating factor-zinc ﬁnger 143 factors
with evolutionary conserved cis-elements. J. Biol. Chem., 279,
7734–7739.
21. Ragoussis,J., Senger,G., Mockridge,I., Sanseau,P., Ruddy,S.,
Dudley,K., Sheer,D. and Trowsdale,J. (1992) A testis-expressed Zn
ﬁnger gene (ZNF76) in human 6p21.3 centromeric to the MHC is
closely linked to the human homolog of the t-complex gene tcp-11.
Genomics, 14, 673–679.
22. Zheng,G. and Yang,Y.C. (2004) ZNF76, a novel transcriptional
repressor targeting TATA-binding protein, is modulated by
sumoylation. J. Biol. Chem., 279, 42410–42421.
23. Myslinski,E., Gerard,M.A., Krol,A. and Carbon,P. (2006) A
genome scale location analysis of human Staf/ZNF143-binding sites
suggests a widespread role for human Staf/ZNF143 in mammalian
promoters. J. Biol. Chem., 281, 39953–39962.
24. Lucibello,F.C., Truss,M., Zwicker,J., Ehlert,F., Beato,M. and
Muller,R. (1995) Periodic cdc25C transcription is mediated by a
novel cell cycle-regulated repressor element (CDE). EMBO J., 14,
132–142.
25. Zwicker,J., Lucibello,F.C., Wolfraim,L.A., Gross,C., Truss,M.,
Engeland,K. and Muller,R. (1995) Cell cycle regulation of the cyclin
A, cdc25C and cdc2 genes is based on a common mechanism of
transcriptional repression. EMBO J., 14, 4514–4522.
26. Uchiumi,T., Longo,D.L. and Ferris,D.K. (1997) Cell cycle regula-
tion of the human polo-like kinase (PLK) promoter. J. Biol. Chem.,
272, 9166–9174.
27. Fontijn,R.D., Goud,B., Echard,A., Jollivet,F., van Marle,J.,
Pannekoek,H. and Horrevoets,A.J. (2001) The human kinesin-like
protein RB6K is under tight cell cycle control and is essential for
cytokinesis. Mol. Cell. Biol., 21, 2944–2955.
28. Myslinski,E., Krol,A. and Carbon,P. (2004) Characterization of
snRNA and snRNA-type genes in the puﬀerﬁsh Fugu rubripes.
Gene, 330, 149–158.
29. Schaub,M., Myslinski,E., Krol,A. and Carbon,P. (1999)
Maximization of selenocysteine tRNA and U6 small nuclear RNA
transcriptional activation achieved by ﬂexible utilization of a Staf
zinc ﬁnger. J. Biol. Chem., 274, 25042–25050.
30. Weinmann,A.S. and Farnham,P.J. (2002) Identiﬁcation of unknown
target genes of human transcription factors using chromatin
immunoprecipitation. Methods, 26, 37–47.
31. Suzuki,Y., Yamashita,R., Nakai,K. and Sugano,S. (2002) DBTSS:
DataBase of human Transcriptional Start Sites and full-length
cDNAs. Nucleic Acids Res., 30, 328–331.
32. Yamashita,R., Suzuki,Y., Wakaguri,H., Tsuritani,K., Nakai,K. and
Sugano,S. (2006) DBTSS: DataBase of Human Transcription Start
Sites, progress report 2006. Nucleic Acids Res., 34, D86–D89.
33. Quandt,K., Frech,K., Karas,H., Wingender,E. and Werner,T.
(1995) MatInd and MatInspector: new fast and versatile tools for
detection of consensus matches in nucleotide sequence data.
Nucleic Acids Res., 23, 4878–4884.
34. Smale,S.T. and Kadonaga,J.T. (2003) The RNA polymerase II core
promoter. Annu. Rev. Biochem., 72, 449–479.
35. Schaub,M., Krol,A. and Carbon,P. (1999) Flexible zinc ﬁnger
requirement for binding of the transcriptional activator staf to U6
small nuclear RNA and tRNA(Sec) promoters. J. Biol. Chem., 274,
24241–24249.
36. Huet,X., Rech,J., Plet,A., Vie,A. and Blanchard,J.M. (1996) Cyclin
A expression is under negative transcriptional control during the
cell cycle. Mol. Cell Biol., 16, 3789–3798.
37. Lange-zu Dohna,C., Brandeis,M., Berr,F., Mossner,J. and
Engeland,K. (2000) A CDE/CHR tandem element regulates cell
cycle-dependent repression of cyclin B2 transcription. FEBS Lett.,
484, 77–81.
38. Fajas,L., Le Cam,L., Polanowska,J., Fabbrizio,E., Servant,N.,
Philips,A., Carnac,G. and Sardet,C. (2000) A CDE/CHR-like
element mediates repression of transcription of the mouse RB2
(p130) gene. FEBS Lett., 471, 29–33.
Nucleic Acids Research, 2007, Vol. 35,No. 10 346339. Tanaka,M., Ueda,A., Kanamori,H., Ideguchi,H., Yang,J.,
Kitajima,S. and Ishigatsubo,Y. (2002) Cell-cycle-dependent regula-
tion of human aurora A transcription is mediated by periodic
repression of E4TF1. J. Biol. Chem., 277, 10719–10726.
40. Zwicker,J., Gross,C., Lucibello,F.C., Truss,M., Ehlert,F.,
Engeland,K. and Muller,R. (1995) Cell cycle regulation of cdc25C
transcription is mediated by the periodic repression of the
glutamine-rich activators NF-Y and Sp1. Nucleic Acids Res., 23,
3822–3830.
41. Myslinski,E., Ame,J.C., Krol,A. and Carbon,P. (2001) An
unusually compact external promoter for RNA polymerase III
transcription of the human H1RNA gene. Nucleic Acids Res., 29,
2502–2509.
42. Baldi,A., Boccia,V., Claudio,P.P., De Luca,A. and Giordano,A.
(1996) Genomic structure of the human retinoblastoma-related
Rb2/p130 gene. Proc. Natl Acad. Sci. USA, 93, 4629–4632.
43. Li,F. and Altieri,D.C. (1999) The cancer antiapoptosis mouse
survivin gene: characterization of locus and transcriptional
requirements of basal and cell cycle-dependent expression.
Cancer Res., 59, 3143–3151.
44. Liu,N., Lucibello,F.C., Engeland,K. and Muller,R. (1998) A new
model of cell cycle-regulated transcription: repression of the cyclin
A promoter by CDF-1 and anti-repression by E2F. Oncogene, 16,
2957–2963.
45. Philips,A., Chambeyron,S., Lamb,N., Vie,A. and Blanchard,J.M.
(1999) CHF: a novel factor binding to cyclin A CHR corepressor
element. Oncogene, 18, 6222–6232.
46. Coisy,M., Roure,V., Ribot,M., Philips,A., Muchardt,C.,
Blanchard,J.M. and Dantonel,J.C. (2004) Cyclin A repression
in quiescent cells is associated with chromatin remodeling
of its promoter and requires Brahma/SNF2alpha. Mol. Cell, 15,
43–56.
3464 Nucleic Acids Research, 2007, Vol. 35, No. 10